PROxy Network, an initiative of PeriPharm Inc.
Montreal, Quebec, H2Y 2H4, Canada
Location status: Recruiting
NCT Number: NCT06786130
The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Montreal, Quebec, H2Y 2H4, Canada
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is an observational study in which participants complete PRO questionnaires via a web platform. No medical intervention or medication is involved.
Time frame: At recruitment
Using the WOrk Productivity and Activity Impairment (WPAI) questionnaire
Time frame: At recruitment
Using the modified Resource Utilization Questionnaire for Type 1 Diabetes (mRUQ-T1DM) questionnaire.
Time frame: At recruitment
Using the EuroQOL-5 dimension-5 levels (EQ-5D-5L) questionnaire.
Time frame: At recruitment
Using the Zarit Burden Interview-22 (ZBI-22) questionnaire.
PeriPharm
Other
Burden and (Dis)Utility of Caregivers of Children With T1D
Acronym: T1D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07767461
Autoimmune Diseases, Contact Dermatitis
Copenhagen, Denmark
View Trial DetailsNCT06575426
Autoimmune Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial DetailsNCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial DetailsNCT07427251
Autoimmune Diseases, Diabetes Mellitus
Herlev, Denmark
View Trial Details